Cadrenal Therapeutics, Inc. Common Stock
Cadrenal Therapeutics, Inc. Common Stock (CVKD) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · CVKD · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
32
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Cadrenal Therapeutics, Inc. Common Stock insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
CVKD insider buying and selling by quarter
CVKD insider selling · CVKD insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · CVKD ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
CVKD executive sell shares · CVKD board member insider trading · CVKD insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 3, 2026 | Pham Quang X CEO and Chairman · Director | Sale | 2,323 | $10K | Form 4 |
| Jun 4, 2026 | Pham Quang X CEO and Chairman · Director | Sale | 3,898 | $17K | Form 4 |
| Jun 5, 2026 | Pham Quang X CEO and Chairman · Director | Sale | 2,064 | $9K | Form 4 |
| May 29, 2026 | Pham Quang X CEO and Chairman · Director | Sale | 303 | $2K | Form 4 |
| Jun 2, 2026 | Pham Quang X CEO and Chairman · Director | Sale | 349 | $2K | Form 4 |
| May 11, 2026 | Pham Quang X CEO and Chairman · Director | Sale | 6,476 | $37K | Form 4 |
| May 12, 2026 | Pham Quang X CEO and Chairman · Director | Sale | 3,298 | $17K | Form 4 |
| May 28, 2026 | Pham Quang X CEO and Chairman · Director | Sale | 2,989 | $15K | Form 4 |
| May 22, 2026 | Pham Quang X CEO and Chairman · Director | Sale | 1,165 | $7K | Form 4 |
| Dec 29, 2025 | Szot Matthew K CFO | Sale | 9,933 | $69K | Form 4 |
| Oct 24, 2025 | Szot Matthew K CFO | Sale | 1,800 | $25K | Form 4 |
| Oct 27, 2025 | Szot Matthew K CFO | Sale | 1,800 | $25K | Form 4 |
| Oct 24, 2025 | Pham Quang X CEO and Chairman · Director | Sale | 1,129 | $16K | Form 4 |
| Oct 27, 2025 | Pham Quang X CEO and Chairman · Director | Sale | 1,315 | $18K | Form 4 |
| Oct 9, 2025 | Szot Matthew K CFO | Sale | 1,693 | $24K | Form 4 |
| Oct 13, 2025 | Szot Matthew K CFO | Sale | 1,800 | $25K | Form 4 |
| Oct 9, 2025 | Pham Quang X CEO and Chairman · Director | Sale | 1,800 | $25K | Form 4 |
| Oct 13, 2025 | Pham Quang X CEO and Chairman · Director | Sale | 1,800 | $25K | Form 4 |
| Oct 6, 2025 | Szot Matthew K CFO | Sale | 107 | $1K | Form 4 |
| Oct 2, 2025 | Pham Quang X CEO and Chairman · Director | Sale | 500 | $7K | Form 4 |
| Sep 29, 2025 | Szot Matthew K CFO | Sale | 100 | $1K | Form 4 |
| Oct 1, 2025 | Szot Matthew K CFO | Sale | 1,700 | $24K | Form 4 |
| Sep 29, 2025 | Pham Quang X CEO and Chairman · Director | Sale | 419 | $6K | Form 4 |
| Oct 1, 2025 | Pham Quang X CEO and Chairman · Director | Sale | 881 | $12K | Form 4 |
| Sep 24, 2025 | Szot Matthew K CFO | Sale | 1,500 | $21K | Form 4 |
Pham Quang X
CEO and Chairman · Director
Date
Jun 3
Shares
2,323
Price
$4.26
Value
$10K
Pham Quang X
CEO and Chairman · Director
Date
Jun 4
Shares
3,898
Price
$4.41
Value
$17K
Pham Quang X
CEO and Chairman · Director
Date
Jun 5
Shares
2,064
Price
$4.42
Value
$9K
Pham Quang X
CEO and Chairman · Director
Date
May 29
Shares
303
Price
$5.01
Value
$2K
Pham Quang X
CEO and Chairman · Director
Date
Jun 2
Shares
349
Price
$4.46
Value
$2K
Pham Quang X
CEO and Chairman · Director
Date
May 11
Shares
6,476
Price
$5.76
Value
$37K
Pham Quang X
CEO and Chairman · Director
Date
May 12
Shares
3,298
Price
$5.28
Value
$17K
Pham Quang X
CEO and Chairman · Director
Date
May 28
Shares
2,989
Price
$4.93
Value
$15K
Pham Quang X
CEO and Chairman · Director
Date
May 22
Shares
1,165
Price
$5.69
Value
$7K
Pham Quang X
CEO and Chairman · Director
Date
Oct 24
Shares
1,129
Price
$14.03
Value
$16K
Pham Quang X
CEO and Chairman · Director
Date
Oct 27
Shares
1,315
Price
$13.99
Value
$18K
Pham Quang X
CEO and Chairman · Director
Date
Oct 9
Shares
1,800
Price
$14.02
Value
$25K
Pham Quang X
CEO and Chairman · Director
Date
Oct 13
Shares
1,800
Price
$14.15
Value
$25K
Pham Quang X
CEO and Chairman · Director
Date
Oct 2
Shares
500
Price
$14.13
Value
$7K
Pham Quang X
CEO and Chairman · Director
Date
Sep 29
Shares
419
Price
$14.01
Value
$6K
Pham Quang X
CEO and Chairman · Director
Date
Oct 1
Shares
881
Price
$14.01
Value
$12K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About CVKD insider trading
CVKD insider trades
Cadrenal Therapeutics, Inc. Common Stock (CVKD) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Pham Quang X (CEO and Chairman · Director), Szot Matthew K (CFO). Over the past 12 months, 2 insiders have filed transactions with the SEC. CVKD insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Cadrenal Therapeutics, Inc. Common Stock's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
CVKD insider trading · 5 questionsThe insiders of Cadrenal Therapeutics, Inc. Common Stock (CVKD) include executives and directors such as Pham Quang X (CEO and Chairman · Director), Szot Matthew K (CFO), among others. Over the past 12 months, 2 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026